Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

BACKGROUND: This post hoc analysis assessed the safety, tolerability and effectiveness of long-term treatment with aripiprazole adjunctive to either bupropion or selective serotonin reuptake inhibitors (SSRIs)/serotonin–norepinephrine reuptake inhibitors (SNRIs) in patients with major depressive dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Clayton, Anita H, Baker, Ross A, Sheehan, John J, Cain, Zachary J, Forbes, Robert A, Marler, Sabrina Vogel, Marcus, Ronald, Berman, Robert M, Thase, Michael E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119176/
https://www.ncbi.nlm.nih.gov/pubmed/25037144
http://dx.doi.org/10.1186/1756-0500-7-459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119176/
https://www.ncbi.nlm.nih.gov/pubmed/25037144
http://dx.doi.org/10.1186/1756-0500-7-459

Ejemplares similares